Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Board Meeting Date

Ipca Laboratories Board Meeting Date

Ipca Laboratories board meeting set for 5 November 2026 to approve Q2 and H1 FY27 unaudited results. Insider trading window remains closed until two days after declaration.

Source

BSE filing, NSE: IPCALAB. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Ipca Laboratories Ltd: key numbers

Share price
₹1,930.50
Market cap
₹48,978 Cr
Revenue (annual)
₹9,646 Cr
Net profit (annual)
₹1,141 Cr
P/E (TTM)
37.4×Sector 46.1×
Promoter holding
44.72%+0.00% QoQ
FII holding
11.53%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Ipca Laboratories Ltd

All →
13:34 IST BSE
Financial Results

Ipca Laboratories Q1 FY27 Results: Net Profit ₹424.3 Cr, Up 82.2% YoY

Ipca Laboratories Ltd reported revenue from operations of ₹2,788 Cr (+20.8% YoY) and net profit of ₹424.3 Cr (+82.2% YoY) for Q1 FY27.

Key figure
Net profit ₹424.3 Cr · +82.2% YoY

Other board meeting date announcements

All →